Smofkabiven Electrolyte Free Emulsion For Infusion
PACKAGE LEAFLET: INFORMATION FOR THE USER
SmofKabiven Electrolyte Free Central
Emulsion for Infusion
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
What is in this leaflet:
1. What SmofKabiven Electrolyte Free Central is and what it is used for
2. What you need to know before you use SmofKabiven Electrolyte Free Central
3. Flow to use SmofKabiven Electrolyte Free Central
4. Possible side effects
5. Howto store SmofKabiven Electrolyte Free Central
6. Contents of the pack and other information
1. What SmofKabiven Electrolyte Free Central is and what it is used for
SmofKabiven Electrolyte Free Central is an emulsion for infusion given into your blood by a drip (intravenous infusion). The product contains amino acids (components used to build proteins), glucose (carbohydrates) and lipids (fat) in a plastic bag.
A health care professional will give you SmofKabiven Electrolyte Free Central when other forms of feeding are not good enough or have not worked.
2. What you need to know before you use SmofKabiven Electrolyte Free Central
if you are allergic (hypersensitive) to active substances or any of the other ingredients of this medicine (listed in section 6)
- if you are allergic to fish or egg
- if you are allergic to peanuts or soya you should not use this product. SmofKabiven Electrolyte Free Central contains soya-bean oil
- if you have too much fat in the blood (hyperlipidaemia)
- if you have serious liver disease
- if you have blood clotting problems (coagulation disorders)
- if your body has problems using amino acids
- if you have serious kidney disease without access to dialysis
- if you are in acute shock
- if you have too much sugar in your blood (hyperglycaemia) which is uncontrolled
- if you have fluid in the lungs (acute pulmonary oedema)
- if you have too much body fluid (hyperhydration)
- if you have heart failure that is not treated
- if you have a defect in your blood clotting system (haemophagocytotic syndrome)
- if you are in an unstable condition, such as after serious trauma, uncontrolled diabetes, acute heart attack, stroke, blood clot (embolism), metabolic acidosis (a disturbance resulting in too much acid in the blood), serious infection (severe sepsis), coma and if you don't have enough body fluid (hypotonic dehydration).
Warnings and precautions
Talk to your doctor before using SmofKabiven Electrolyte Free Central if you have:
- kidney problems
- diabetes mellitus
- pancreatitis (inflammation of the pancreas)
- liver problems
- hypothrodism (toxic goiter)
- sepsis (serious infection)
If during the infusion you get fever, rash, swelling, difficulty in breathing, chills, sweating, nausea or vomiting, tell the health care professional immediately because these symptoms might be caused by an allergic reaction or that you have been given too much of the medicine.
Your doctor may regularly need to check your blood for liver function tests and other values.
Children and adolescent
SmofKabiven Electrolyte Free Central is not meant for newborn babies or children younger than 2 years old. At the moment, there is no experience of the use of SmofKabiven Electrolyte Free Central in children from 2 to 11 years old.
Other medicines and SmofKabiven Electrolyte Free Central
Tell your doctor if you are taking, have recently taken or might take any other medicines, even without prescription.
Pregnancy and breast-feeding
Data from using SmofKabiven Electrolyte Free Central during pregnancy or breast-feeding is lacking. SmofKabiven Electrolyte Free Central should therefore be given to pregnant or breastfeeding women only if the doctor find it necessary. The use of SmofKabiven Electrolyte Free Central may be considered during pregnancy and breastfeeding, as advised by your doctor
Driving and using machines
Not relevant as the medicine is given at the hospital.
3. How to use SmofKabiven Electrolyte Free Central
Always use this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Your doctor will decide on the dose for you individually depending on your body weight and function. SmofKabiven Electrolyte Free Central will be given to you by a health care professional.
If you use more SmofKabiven Electrolyte Free Central than you should
It is unlikely that you will receive too much medicine as SmofKabiven Electrolyte Free Central is given to you by a health care professional.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people):
• a slightly raised body temperature.
Uncommon (may affect up to 1 in 100 people):
• high blood (plasma) levels of compounds from the liver
• lack of appetite
• nausea
• vomiting
• chills
• dizziness
• headache.
Rare (may affect up to 1 in 1,000 people):
• low or high blood pressure
• difficulty in breathing
• fast heart beat (tachycardia)
• Hypersensitivity reactions that can give symtoms like swelling, fever, fall in blood pressure, skin rashes, wheals (raised red areas), flushing, headache
• Sensations of hot and cold
• Pain in the neck, back, bones and breast
• Paleness.
• Light blue coloured lips and skin because of too little oxygen in the blood
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
For UK - You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
For Ireland - You can report directly via;
HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
Website: www.hpra.ie
e-mail: medsafety@hpra.ie
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store SmofKabiven Electrolyte Free Central
Keep this medicine out of the sight and reach of children.
Store in overpouch. Do not store above 25°C. Do not freeze.
Do not use this medicine after the expiry date which is stated on the label on the bag and box. The expiry date refers to the last day of that month.
Compatibility
Only medicinal or nutrition solutions for which compatibility has been documented may be added to Smofkabiven Electrolyte Free Central. Compatibility for different additives and the storage time of the different admixtures will be available upon request. Additions should be made aseptically.
Shelf-life after mixing
Chemical and physical in-use stability of the mixed three chamber bag has been demonstrated for 56 hours at 25°C. From a microbiological point of view the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8°C.
Shelf-life after mixing with additives
From a microbiological point of view, the product should be used immediately when additions have been made. If not used immediately, the in-use storage time and conditions prior to use are the responsibility of the user and should normally not be longer than 24 hours at 2-8°C.
The following information is intended for healthcare professionals only:
Warnings and precautions for use
To avoid risks associated with too rapid infusion rates, it is recommended to use a continuous and well-controlled infusion, if possible by using a volumetric pump.
Since an increased risk of infection is associated with the use of any central vein, strict aseptic precautions should be taken to avoid any contamination especially during catheter insertion.
Serum glucose, electrolytes and osmolarity as well as fluid balance, acid-base status and liver and enzyme tests should be monitored.
Any sign or symptom of anaphylactic reaction (such as fever, shivering, rash or dyspnoea) should lead to immediate interruption of the infusion.
Smofkabiven Electrolyte Free Central should not be given simultaneously with blood in the same infusion set due to the risk of pseudoagglutination.
Method of administration
Intravenous use, infusion into a central vein.
To provide total parenteral nutrition, trace elements, electrolytes and vitamins should be added to Smofkabiven Electrolyte Free Central according to the patients need.
Infusion rate
The maximum infusion rate for glucose is 0.25 g/kg bw/h, for amino acid 0.1 g/kg bw/h, and for fat 0.15 g/kg bw/h.
The infusion rate should not exceed 2.0 ml/kg bw/h (corresponding to 0.25 g glucose, 0.10 g amino acids, and 0.08 g fat/kg bw/h). The recommended infusion period is 14-24 hours.
Precautions for disposal
Do not use if package is damaged. Use only if the amino acid and glucose solutions are clear and colourless or slightly yellow and the lipid emulsion is white and homogenous. The contents of the three separate chambers have to be mixed before use, and before any additions are made via the additive port.
After separation of the peelable seals the bag should be inverted on a number of occasions to ensure a homogenous mixture, which does not show any evidence of phase separation.
For single use only. Any unused solution remaining after infusion should be discarded.
Instructions for use
The bag
® Notches in the overpouch © Handle
© Hole for hanging the bag © Peelable seals
© Blind port (only used during Manufacturing) © Additive port © Infusion port ® Oxygen absorber
1. Removal of overpouch
• To remove overpouch, hold the bag horizontally and tear from the notch close to the ports along the upper edge (A).
FRESENIUS
KABI
• Then simply tear the long side, pull off the
overpouch and discard it along with the V005/UP
oxygen absorber (B). xxx xxx
A
• Mix the contents of the three chambers by inverting the bag three times until the components are thoroughly mixed.
• Shortly before inserting the infusion set, break off the tamper evident arrow flag from the blue infusion port (A).
Please note: The membrane in the infusion port is sterile.
• Use a non-vented infusion set or close the air-inlet on a vented set.
• Hold the base of the infusion port.
• Push the spike through the infusion port.
The spike should be fully inserted to secure it in place. Please note: The inner part of the infusion port is sterile.
• Place the bag on a flat surface.
• Roll up the bag tightly from the handle side towards the ports, firstly with the right hand and then applying a constant pressure with the left hand until the vertical seals are broken. The vertical peel seals open due to the pressure of the fluid. The peel seals can also be opened before removing the overpouch.
Please note: The liquids mix easily although the horizontal seal remains closed.
• Place the bag on a flat surface again. Shortly before injecting the additives, break off the tamper-evident arrow flag from the white additive port (A).
Please note: The membrane in the additive port is sterile.
• Hold the base of the additive port. Insert the needle, inject the additives (with known compatibility) through the centre of the injection site (B).
• Mix thoroughly between each addition by inverting the bag three times. Use syringes with needles of 18-23 gauge and a length of max. 40 mm.
• Hang the bag up by the hole below the handle.
6. Contents of the pack and other information
What SmofKabiven Electrolyte Free Central contains
The active substances are g per 1000 ml
Manufacturer:
Fresenius Kabi AB, SE-751 74 Uppsala, Sweden This leaflet was last revised in 01/2015
The other ingredients are: glycerol, purified egg phospholipids, all-rac-a-tocopherol, sodium hydroxide (pH adjustment), sodium oleate, glacial acetic acid (pH adjustment), hydrochloric acid (pH adjustment) and water for injections.
What SmofKabiven Electrolyte Free Central looks like and contents of the pack
Glucose and amino acid solutions are clear and colourless or slightly yellow and free from particles. The lipid emulsion is white and homogenous.
Pack sizes:
1 x 493 ml, 6 x 493 ml 1 x 986 ml, 4 x 986 ml 1 x 1477 ml, 4 x 1477 ml 1 x 1970 ml, 4 x 1970 ml 1 x 2463 ml, 3 x 2463 ml
Marketing Authorisation Holder and Manufacturer
Marketing authorisation holder:
Fresenius Kabi Ltd
Cestrian Court Eastgate Way Manor Park Runcorn Cheshire
WA71NT United Kingdom
FRESENIUS
KABI
V003/UP xxx xxx